“…NDV-HK84 is a wild-type OV. A study found that NDV-HK84 could inhibit tumor growth and had an oncolytic effect by activating IFN signaling in vitro and in vivo HCC models [93 , 94] . The applications of genetically engineered NDV in HCC treatment have been investigated for years.…”